Stock listing
Ars Pharmaceuticals, Inc.
Selected listing: SPRY · NASDAQ · USD · US
Ars Pharmaceuticals, Inc. (NASDAQ:SPRY), Health Technology. Latest release Oct 5, 2026: ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact…
- Ticker
- NASDAQ:SPRY
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Ars Pharmaceuticals, Inc.
Ars Pharmaceuticals, Inc. is a public company traded under the ticker SPRY in the American market. It focuses on developing innovative therapies to address unmet medical needs.
Latest news from Ars Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
October 5, 2026
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
August 13, 2026
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
August 3, 2026
ARS Pharmaceuticals Announces CEO Succession
July 7, 2026
ARS Pharmaceuticals Provides Commercial and Financial Updates
June 23, 2026
Events
Research Ars Pharmaceuticals, Inc.
Ars Pharmaceuticals, Inc. company profile
View the public company page for Ars Pharmaceuticals, Inc. on 6ix.
Ars Pharmaceuticals, Inc. news
Read company news and market updates connected to Ars Pharmaceuticals, Inc..
Ars Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Ars Pharmaceuticals, Inc..